Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.59 |
| ▸ | CTSS | P25774 | 5/20 | 0.56 |
| ▸ | PPARG | P37231 | 2/20 | 0.54 |
| ▸ | KLK7 | P49862 | 2/20 | 0.50 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.50 |
| ▸ | SYK | P43405 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 6/20 | 0.45 |
| ▸ | REN | P00797 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CTSL | P07711 | 2/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | CDC25B | P30305 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5349842 | 1.00 | PPARA (0.59) | PPARACTSSPPARGKLK7KLK5 | |
| SCHEMBL8906370 | 1.00 | PPARA (0.59) | PPARACTSSPPARGKLK7KLK5 | |
| SCHEMBL6042808 | 0.92 | PPARA (0.61) | PPARACTSSPPARGKLK7KLK5 | |
| SCHEMBL6043892 | 0.92 | PPARA (0.61) | PPARACTSSPPARGKLK7KLK5 | |
| SCHEMBL5710546 | 0.92 | PPARA (0.61) | PPARACTSSPPARGKLK7KLK5 | |
| SCHEMBL3783761 | 0.89 | PPARA (0.70) | PPARACTSSPPARGKLK7KLK5 | |
| SCHEMBL27910918 | 0.83 | PPARA (0.52) | PPARACTSSPPARGSYKCTSK | |
| SCHEMBL27675050 | 0.82 | PPARA (0.56) | PPARACTSSPPARGKLK7KLK5 | |
| SCHEMBL12053946 | 0.82 | PPARA (0.56) | PPARACTSSPPARGKLK7KLK5 | |
| SCHEMBL7518373 | 0.81 | PPARA (0.74) | PPARACTSSPPARGKLK7KLK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5659065-A | CHEMICAL INTERMEDIATES FOR MEDICINAL ACTIVE AGENTS | NOVARTIS CORPORATION (US) | 1997-08-19 | — | — | US | disclosed |
| EP-0678500-A1 | Alpha-amino alkanoic acids and reduction products as intermediates in the preparation of renin inhibitors | CIBA-GEIGY AG (CH) | 1995-10-25 | — | — | EP | disclosed |